e-learning
resources
Milan 2017
Sunday, 10.09.2017
Current challenges in COPD evaluation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Malnutrition and sarcopenia in chronic obstructive pulmonary disease according to the new ESPEN definition and EWGSOP criteria
F. de Blasio (Pozzuoli, NA, Italy)
Source:
International Congress 2017 – Current challenges in COPD evaluation
Session:
Current challenges in COPD evaluation
Session type:
Poster Discussion
Number:
400
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. de Blasio (Pozzuoli, NA, Italy). Malnutrition and sarcopenia in chronic obstructive pulmonary disease according to the new ESPEN definition and EWGSOP criteria. 400
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Recommendations of the ATS/ERS Task Force for the definition of outcomes for COPD pharmacological trials
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006
Osteoporosis, sarcopenia and pulmonary hypertension in relation to GOLD classification vs BODE index in COPD
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Do GOLD stages of COPD severity really correspond to differences in health status?
Source: Eur Respir J 2003; 22: 444-449
Year: 2003
Hypertension in chronic obstructive pulmonary disease (COPD): A review of current practice
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
Monitoring of COPD. A review of current guidelines‘ recommendations
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
Management of chronic obstructive pulmonary disease: compliance with the Swiss guidelines
Source: Eur Respir J 2004; 24: Suppl. 48, 13s
Year: 2004
Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Dietary habits in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Socioeconomic status shaping GOLD A-D classification in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Obesity and impairments in chronic obstruction pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Chronic obstructive pulmonary disease an underperceived disease: the PLATINO study
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008
Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Chronic obstructive pulmonary disease (COPD) assessment service: guidelines for referral and accuracy of clinical assessment
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005
Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006
Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Chronic obstructive pulmonary disease and myocardial infarction: Special aspects of clinical course in comorbid conditions
Source: International Congress 2014 – Predictors
Year: 2014
Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept